News

Good morning, ladies and gentlemen, and welcome to the Alaska Air Group 2025 First Quarter Earnings Call. At this time, all participants have been placed on mute to prevent background noise. Today's ...
This partnership merges BioSkryb's single cell amplification and multi-omics chemistry with 1Cell.Ai's OncoIncytes platform, creating a groundbreaking ... a powerful synergy of visionary science ...
In our view, Carvana is well on its way to becoming a widely recognized, high-quality business ... background checks. In 2024, it acquired Sterling Check, the second-largest player, creating ...
Zeneara positions itself as a unique, plant-based tinnitus supplement that introduces what it calls the "Mute Button ...
This partnership merges BioSkryb's single cell amplification and multi-omics chemistry with 1Cell.Ai's OncoIncytes platform, creating a groundbreaking solution ... "This collaboration represents a ...
The XtaLAB Synergy-ED incorporates 3D ED/MicroED ... methods and analytical technologies. Through this partnership, Rigaku and SPERA PHARMA aim to provide robust support at the forefront of ...
US President Donald Trump's decision to impose punitive tariffs of 145% for pharmaceutical imports from China,1 effective since April 10, 2025, will pose substantial challenges towards global health ...
How CDMOs are reshaping pharmaceutical partnerships through friendshoring, risk-sharing economics, and specialized development capabilities.
Azitra Inc., a Branford-based biopharmaceutical firm, said Thursday it has entered into a share purchase agreement with New York-based institutional investor Alumni Capital LP  that it expects will ...
Citeline and Norstella have completed a merger, first announced in June, to create one of the largest ... under the name Pharma Intelligence, ahead of a rebranding earlier this year.